ZORAN ZDRAVESKI
CIK 1741285 · See Remarks · last filed 2026-01-22
ZORAN ZDRAVESKI is a corporate insider who has filed 16 SEC Form 4 insider transactions across 2 companies since 2018. The most recent filing, for TCRX, was dated Jan 22, 2026. Across all open-market trades the lifetime net is −$1.3M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $4.3K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$4.3K
2
16
-$1.30M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| TCRX | See Remarks | 4,716 | $0.91 | $4.3K | -$916.9K | 9 | 2026-01-22 |
| Dianthus Therapeutics, Inc. /DE/ (MGTA) Delisted | See Remarks | 140,092 | $11.19 | $1.57M | -$386.9K | 7 | 2021-02-16 |
Recent Filings
16 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-01-22 | TCRX | Grant (A) | — | $0 | EDGAR |
| 2025-02-11 | TCRX | Grant (A) | — | $0 | EDGAR |
| 2024-08-27 | TCRX | Mixed | −7,500 | -$420.6K | EDGAR |
| 2023-06-15 | TCRX | Grant (A) | — | $0 | EDGAR |
| 2023-02-06 | TCRX | Grant (A) | — | $0 | EDGAR |
| 2022-07-27 | TCRX | Grant (A) | — | $0 | EDGAR |
| 2022-01-20 | TCRX | Grant (A) | — | $0 | EDGAR |
| 2021-09-27 | TCRX | Buy (P) | +4,716 | $35.3K | EDGAR |
| 2021-09-09 | TCRX | Grant (A) | — | $0 | EDGAR |
| 2021-02-16 | Dianthus Therapeutics, Inc. /DE/ (MGTA) Delisted | Grant (A) | — | $0 | EDGAR |